Therefore, further research is needed to explore the precise molecular mechanism and the multifaceted role of PRAT-derived chemerin in tumor development, considering that chemerin inhibitors have already been proposed as potential modulators of the anti-tumor immune response [21]. The gene discussed is RARRES2; the disease is neoplasm.